Evidence map›Paper›PMID 41259166›Full record

ArticleIEEE journal of biomedical and health informatics2026

HIBMatch: Hypergraph Information Bottleneck for Semi-Supervised Alzheimer's Progression.

Zhongying Deng, Shujun Wang, Angelica I Aviles-Rivero, Zoe Kourtzi, Carola-Bibiane Schonlieb

Abstract read
In one paragraph

Article in IEEE journal of biomedical and health informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhongying Deng
Shujun Wang
Angelica I Aviles-Rivero
Zoe Kourtzi
Carola-Bibiane Schonlieb

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease progression prediction is critical for patients with early Mild Cognitive Impairment (MCI) to enable timely intervention and improve their quality of life. While existing progression prediction techniques demonstrate potential with multimodal data, they are highly limited by their reliance on labelled data and fail to account for a key element of future progression prediction: not all features extracted at the current moment may be relevant for predicting progression several years later. To address these limitations in the literature, we design a novel semi-supervised multimodal learning hypergraph architecture, termed HIBMatch, by harnessing hypergraph knowledge based on information bottleneck and consistency regularisation strategies. Firstly, our framework utilises hypergraphs to represent multimodal data, encompassing both imaging and non-imaging modalities. Secondly, to harmonise relevant information from the currently captured data for future MCI conversion prediction, we propose a Hypergraph Information Bottleneck (HIB) that discriminates against irrelevant information, thereby focusing exclusively on harmonising relevant information for future MCI conversion prediction. Thirdly, our method enforces consistency regularisation between the HIB and a discriminative classifier to enhance the robustness and generalisation capabilities of HIBMatch under both topological and feature perturbations. Finally, to fully exploit the unlabeled data, HIBMatch incorporates a cross-modal contrastive loss for data efficiency. Extensive experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset demonstrate that our proposed HIBMatch framework surpasses existing state-of-the-art methods in Alzheimer's disease prognosis.

Indexed as

Alzheimer DiseaseImage Interpretation, Computer-AssistedSupervised Machine LearningAlgorithmsBrainCognitive DysfunctionDisease ProgressionHumans

Identifiers

PMID41259166
PMCPMC13286480

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.